“…Bufadienolides, including resibufogenin, cinobufagin, bufalin, bufotalin and arenobufagin, are a type of steroidal cardiac glycosides (17) that exhibit a variety of biological effects, including cardiotonic, anesthetic and antineoplastic activities (18). Bufalin, as a major active compound of bufadienolide, has been demonstrated to possess significant anti-proliferative activities and apoptosis-inducing effects on human leukaemia, liver, prostatic, endometrial and ovarian cancer cells (19,20). In the present study, we found that another two bufadienolides, resibufogenin and cinobufagin (derived from cinobufacini), inhibit the proliferation of HepG 2 cells in a dose-and time-dependent manner.…”